RECRUITING

Extracorporeal Shockwave Therapy for Spasticity in People With Spinal Cord Injury

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

People with spinal cord injury (SCI) experience a host of secondary complications that can impact their quality of life and functional independence. One of the more prevalent complications is spasticity, which occurs in response to spinal cord damage and the resulting disruption of motor pathways. Common symptoms include spasms and stiffness, and can occur more than once per hour in many people with SCI. Spasticity can have a negative impact over many quality of life domains, including loss of functional independence, activity limitations, and even employment. Its impact on health domains is also pronounced, with many people who have spasticity reporting mood disorders, depression, pain, sleep disturbances, and contractures. Spasticity can interfere with post-injury rehabilitation and lead to hospitalization. There are many treatments for spasticity in this population. However, many do not have long-term efficacy, and, if they do, they are often pharmacological in nature and carry side effects that could limit function or affect health. The goal of this pilot, randomized-controlled study is to investigate the potential efficacy and safety of a non-invasive treatment with a low side effect profile, extracorporeal shockwave therapy (ESWT). ESWT has shown some benefits in people with post-stroke spasticity with no long term side effects. Thirty individuals with chronic, traumatic SCI will be recruited. Fifteen will be provided with ESWT while the other fifteen will be given a sham treatment. Clinical and self-report measures of spasticity and its impact on quality of life will be collected, as well as quantitative ultrasound measures of muscle architecture and stiffness. The ultimate goal of this pilot project is to collect the data necessary to apply for a larger randomized-controlled trial. Conducting a larger trial will allow for a more powerful estimation of safety and efficacy of ESWT as a treatment for spasticity in people with SCI.

Official Title

Effect of Extracorporeal Shockwave Therapy on Spasticity in Chronic SCI: A Pilot Study

Quick Facts

Study Start:2022-09-01
Study Completion:2025-02-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05432999

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. 18 years of age or older.
  2. 2. Have a non-progressive traumatic SCI (complete or incomplete) with residual neurological deficits that occurred greater than 1 year prior to their enrollment.
  3. 3. MAS score of 2 or greater in the gastrocnemius of the treated limb.
  4. 4. Can be treated with shockwaves. Contraindications include current or recent (within the past 3 months) infection at the site of treatment and severe coagulopathies (e.g. hemophilia).164
  5. 5. No change in antispasmodic medications within the past three months or intended changes over the course of the trial.
  6. 6. Participant is able and willing to comply with the protocol.
  1. 1. History of surgical procedures of the lower extremity.
  2. 2. Ankle contracture.
  3. 3. Sever, inflammatory arthritic diseases.
  4. 4. Thrombosis.
  5. 5. Anticoagulant medications.
  6. 6. Pregnancy.
  7. 7. Cancer.
  8. 8. Recent history of local injection of botulinum toxin within 6 months, or phenol/alcohol with 12 months.

Contacts and Locations

Study Contact

Nathan Hogaboom, PhD
CONTACT
9733243584
nhogaboom@kesslerfoundation.org
Shalaka Paranjpe, MS
CONTACT
9733246643
sparanjpe@kesslerfoundation.org

Study Locations (Sites)

Kessler Foundation
West Orange, New Jersey, 07052
United States

Collaborators and Investigators

Sponsor: Kessler Foundation

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-09-01
Study Completion Date2025-02-01

Study Record Updates

Study Start Date2022-09-01
Study Completion Date2025-02-01

Terms related to this study

Keywords Provided by Researchers

  • shockwave
  • extracorporeal shockwave therapy
  • spinal cord injury
  • spasticity

Additional Relevant MeSH Terms

  • Spinal Cord Injuries
  • Spasticity, Muscle
  • Spastic Paraplegia
  • Spastic Quadriplegia
  • Spastic Tetraplegia
  • Paraplegia
  • Tetraplegia